BlackEarth confirms quality graphite flake

Published 06-JUL-2018 14:38 P.M.

|

2 minute read

Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.

In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.

The below articles were written under our previous business model. We have kept these articles online here for your reference.

Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.


Click Here to View Latest Articles

BlackEarth Minerals NL (ASX:BEM) remains on track to define a JORC Resource at its Razafy graphite prospect at the Maniry Project in southern Madagascar within the next four to five weeks.

BEM’s Madagascan projects consist of two primary exploration areas: the main Maniry project in the south, and the Ianapera project in the north. Maniry is highly prospective for large-scale, high-quality graphite deposits and is currently at an advanced evaluation stage pending additional work to establish an initial Resource.

The company now reports that it has received a mineralogical report undertaken by Townend Mineralogy Laboratory on 19 samples taken from Razafy.

The detailed report, which is consistent with findings from an earlier preliminary mineralogical report confirms that very large flakes (>500 micron) occur frequently within the two drilled and tested lenses currently making up the Razafy prospect.

All samples returned significant 500+ micron flakes (up to 2900 micron) and over 60 percent returned 2000+ micron flakes. Significant flakes exist in excess of 850 microns which attracts a premium price in the expandable graphite market.

Of course, as with all minerals exploration, success is not guaranteed — consider your own personal circumstances before investing, and seek professional financial advice.

Photomicrographs of 2 Razafy samples reviewed by Townend:

Notably, these flakes are free of any deleterious contaminants. The lack of deleterious minerals inside the flakes also suggests the potential for high purity graphite production which is used in higher value end products (Li-ion batteries).

Managing Director, Tom Revy commented: “This report by globally respected Townend Mineralogy Laboratory, reaffirms the Board’s decision to fast track the Maniry Graphite Project. The company has met every milestone it set itself pre-IPO to date including drill commencement, assay reporting, average daily drill metres and completion of detailed mineralogy.

“BEM is still on target to define a JORC Resource at Razafy within the next four to five weeks and complete a scoping study on the Maniry Graphite Project by the end of 2018. The upcoming metallurgical test work will provide final flake size distribution which is regarded as critical to project economics.”

Drilling continues at Haja, located two kilometres south of Razafy, with reports of very wide zones of graphitic schist logged to date. Approximately 600 metres of drilling has been completed at Haja with assays to follow next month.



General Information Only

S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.

Conflicts of Interest Notice

S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.

Publication Notice and Disclaimer

The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.

Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.

This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.

 

Discover Small Cap
Biotech Stocks

Join thousands of other Investors following our stock commentary for Free

X